 | • レポートコード：C9J05287 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥444,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥562,400 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥740,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国におけるバイオ後続品市場について調査・分析したレポートで、バイオ後続品の世界市場動向、市場規模、主要企業情報などが含まれています。バイオ後続品の種類別には、抗体、ホルモン、増殖因子、その他に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・バイオ後続品産業の概要 ・バイオ後続品の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のバイオ後続品市場 2014年-2019年 ・世界及び中国のバイオ後続品市場現状 ・企業別分析：Pfizer, Roche, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Johnson& Johnson, Novo Nordisk, Merckなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：抗体、ホルモン、増殖因子、その他 ・世界及び中国のバイオ後続品市場予測 2019年-2024年 ・バイオ後続品の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のバイオ後続品市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilar manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Biosimilar market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Biosimilar industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Biosimilar industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Biosimilar Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Biosimilar as well as some small players. At least 9 companies are included:
* Pfizer
* Roche
* Eli Lilly
* Bayer
* Amgen
* Sanofi-Aventis
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Biosimilar market in gloabal and china.
* Antibody
* Hormone
* Growth Factors
* Other
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Tumor
* Diabetes
* Cardiovascular
* Hemophilia
* Other
Reasons to Purchase this Report:
* Estimates 2019-2024 Biosimilar market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Biosimilar Industry
1.1 Brief Introduction of Biosimilar
1.2 Development of Biosimilar Industry
1.3 Status of Biosimilar Industry
Chapter Two Manufacturing Technology of Biosimilar
2.1 Development of Biosimilar Manufacturing Technology
2.2 Analysis of Biosimilar Manufacturing Technology
2.3 Trends of Biosimilar Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Roche
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Eli Lilly
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Bayer
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Amgen
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Sanofi-Aventis
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Johnson& Johnson
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Biosimilar
4.1 2014-2019 Global Capacity, Production and Production Value of Biosimilar Industry
4.2 2014-2019 Global Cost and Profit of Biosimilar Industry
4.3 Market Comparison of Global and Chinese Biosimilar Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Biosimilar
4.5 2014-2019 Chinese Import and Export of Biosimilar
Chapter Five Market Status of Biosimilar Industry
5.1 Market Competition of Biosimilar Industry by Company
5.2 Market Competition of Biosimilar Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Biosimilar Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Biosimilar Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Biosimilar
6.2 2019-2024 Biosimilar Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Biosimilar
6.4 2019-2024 Global and Chinese Supply and Consumption of Biosimilar
6.5 2019-2024 Chinese Import and Export of Biosimilar
Chapter Seven Analysis of Biosimilar Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Biosimilar Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Biosimilar Industry
Chapter Nine Market Dynamics of Biosimilar Industry
9.1 Biosimilar Industry News
9.2 Biosimilar Industry Development Challenges
9.3 Biosimilar Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Biosimilar Industry
Tables and Figures
Figure Biosimilar Product Picture
Table Development of Biosimilar Manufacturing Technology
Figure Manufacturing Process of Biosimilar
Table Trends of Biosimilar Manufacturing Technology
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
Figure Biosimilar Product and Specifications
Table 2014-2019 Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Biosimilar Production Global Market Share
……
……
Table 2014-2019 Global Biosimilar Capacity List
Table 2014-2019 Global Biosimilar Key Manufacturers Capacity Share List
Figure 2014-2019 Global Biosimilar Manufacturers Capacity Share
Table 2014-2019 Global Biosimilar Key Manufacturers Production List
Table 2014-2019 Global Biosimilar Key Manufacturers Production Share List
Figure 2014-2019 Global Biosimilar Manufacturers Production Share
Figure 2014-2019 Global Biosimilar Capacity Production and Growth Rate
Table 2014-2019 Global Biosimilar Key Manufacturers Production Value List
Figure 2014-2019 Global Biosimilar Production Value and Growth Rate
Table 2014-2019 Global Biosimilar Key Manufacturers Production Value Share List
Figure 2014-2019 Global Biosimilar Manufacturers Production Value Share
Table 2014-2019 Global Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Biosimilar Production
Table 2014-2019 Global Supply and Consumption of Biosimilar
Table 2014-2019 Import and Export of Biosimilar
Figure 2018 Global Biosimilar Key Manufacturers Capacity Market Share
Figure 2018 Global Biosimilar Key Manufacturers Production Market Share
Figure 2018 Global Biosimilar Key Manufacturers Production Value Market Share
Table 2014-2019 Global Biosimilar Key Countries Capacity List
Figure 2014-2019 Global Biosimilar Key Countries Capacity
Table 2014-2019 Global Biosimilar Key Countries Capacity Share List
Figure 2014-2019 Global Biosimilar Key Countries Capacity Share
Table 2014-2019 Global Biosimilar Key Countries Production List
Figure 2014-2019 Global Biosimilar Key Countries Production
Table 2014-2019 Global Biosimilar Key Countries Production Share List
Figure 2014-2019 Global Biosimilar Key Countries Production Share
Table 2014-2019 Global Biosimilar Key Countries Consumption Volume List
Figure 2014-2019 Global Biosimilar Key Countries Consumption Volume
Table 2014-2019 Global Biosimilar Key Countries Consumption Volume Share List
Figure 2014-2019 Global Biosimilar Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Biosimilar Consumption Volume Market by Application
Table 89 2014-2019 Global Biosimilar Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Biosimilar Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Biosimilar Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Biosimilar Consumption Volume Market by Application
Figure 2019-2024 Global Biosimilar Capacity Production and Growth Rate
Figure 2019-2024 Global Biosimilar Production Value and Growth Rate
Table 2019-2024 Global Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Biosimilar Production
Table 2019-2024 Global Supply and Consumption of Biosimilar
Table 2019-2024 Import and Export of Biosimilar
Figure Industry Chain Structure of Biosimilar Industry
Figure Production Cost Analysis of Biosimilar
Figure Downstream Analysis of Biosimilar
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Biosimilar Industry
Table Biosimilar Industry Development Challenges
Table Biosimilar Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Biosimilars Project Feasibility Study
ｍAbバイオシミラー市場：世界及び中国の市場分析・予測（～2024年） mAb Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global mAb Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the mAb Biosimilar manufacturers and is a va…- レミケードバイオシミラー市場：世界及び中国の市場分析・予測（～2024年） Remicade Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Remicade Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Remicade Biosimilar manufactur…
- バイオシミラー試験及び開発サービス市場：世界及び中国市場分析・予測（～2024年） Biosimilar Testing and Development Services Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilar Testing and Development Services industry with a focus on the Chinese market. The report provides key statistics on the mar…
- 神経バイオシミラー生物製剤市場：世界及び中国市場分析・予測（～2024年） Nerve Biosimilar Biological Products Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nerve Biosimilar Biological Products industry with a focus on the Chinese market. The report provides key statistics on the market status of …
- ヘレセプチンバイオシミラーの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Hereceptin Biosimilar is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Hereceptin Biosimilar in gl…